Leukemia Clinical Studies

Some of the many Hematology/Oncology research opportunities available related to leukemia are listed below. Select a study to review a brief description and requirements. Parents or guardians of children who might be eligible are encouraged to inquire about enrollment. Contact information is provided at the end of each study.

Please note that Pilot and Phase I studies are the most experimental and should be considered only after other treatments or trials have been attempted without success.

Thank you for exploring these opportunities and helping us to find cures and prevent childhood disease.

Clinical Studies

Researchers

Acute Lymphoblastic Leukemia and B-Lineage Lymphoma Treatment via Risk-Adapted Chemotherapy – Phase III

Risk-Adapted Chemotherapy in Treating Younger Patients with Newly Diagnosed Standard-Risk B-Acute Lymphoblastic Leukemia or localized B-Lineage Lymphoblastic Lymphoma

Read more

Acute Lymphoblastic Leukemia Cell Banking Study

Proper Protocols for Collecting and Banking Relapsed Acute Lymphoblastic Leukemia Research Specimens

Read more

Acute Myeloid Leukemia trial using Bortezomib and Sorafenib – Phase III

Trial for Patients with de novo Acute Myeloid Leukemia using Bortezomib and Sorafenib for Patients with High Allelic Ratio FLT3/ITD

Read more

Acute Promyelocytic Leukemia Treatment using Arsenic Trioxide and All Trans-Retinoic Acid – Phase III

Study for Patients with Newly Diagnosed Acute Promyelocytic Leukemia using Arsenic Trioxide and All Trans-Retinoic Acid

Read more

High-Risk Acute Lymphoblastic Leukemia Treatment with Combination Chemotherapy – Phase III

Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia, Testing Clofarabine in the Very High Risk Stratum

Read more

Non-Hodgkin Lymphoma or B-Cell Leukemia Evaluation of Rituximab– Phase II/III

Intergroup Trial for Children or Adolescents with B-cell Non-Hodgkin Lymphoma or Mature B-cell Leukemia: Evaluation of Rituximab Efficacy and Safety in High Risk Patients

Read more

T-cell Lymphoblastic Leukemia and Lymphoma Treatment with Bortezomib – Phase III

Bortezomib on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LLy)

Read more

Linda M. McAllister-Lucas, MD, PhD

Read more

Cheryl A Hillery, MD

Read more

Debra E. Cohen, MD

Read more

James D Cooper, MD

Read more

Melvin Deutsch, MD

Read more

Erika Dawn Friehling, MD

Read more

James Anthony Graves, PhD, MD

Read more

Lynn M Malec, MD

Read more

Scott H Maurer, MD

Read more

Linda M. McAllister-Lucas, MD, PhD

Read more

Amma Twumwa Owusu-Ansah, MD

Read more

Edward V. Prochownik, MD, PhD

Read more

A. Kim Ritchey, MD

Read more

Jean M. Tersak, MD

Read more

Randy M Windreich, MD

Read more

Michael R. Wollman, MD

Read more